Physician profile
Marisa Palumbo
NPI 1982869988
$1,424.37
in general payments reported to CMS, 2019-2025
14 companies · $622 in 2025
The $622 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.17 · 2020: $36.25 · 2021: $107 · 2022: $198 · 2023: $224 · 2024: $219 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $290.76 | 2025 | |
| Bausch & Lomb Americas INC. | $245.01 | 2024-2025 | Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $188.05 | 2023 | Acuvue |
| Amgen INC. | $123.27 | 2024 | Tepezza |
| Abbvie INC. | $109.92 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $107.56 | 2020-2022 | |
| Oyster Point Pharma, INC. | $99.49 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $73.21 | 2022-2025 | Rocklatan, Eysuvis, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $52.24 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $47.82 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.19 | 2021 | |
| Sight Sciences, INC. | $22.95 | 2022 | |
| Allergan, INC. | $21.73 | 2021 | |
| Coopervision INC. | $18.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Palumbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.